PCP Consensus Sequences of Flaviviruses: Correlating Variance with Vector Competence and Disease Phenotype

Journal of Molecular Biology

Volumn 396, Issue 3, 2010, Pages 550-563

  Danecek, Petr ^a   Lu, Wenzhe ^a   Schein, Catherine H ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Arthropod borne virus; Dengue hemorrhagic disease; Functional motifs; Vaccine design; West Nile encephalitis

Indexed keywords

ARTHROPOD; ARTICLE; CONSENSUS SEQUENCE; DENGUE VIRUS 1; DENGUE VIRUS 4; DISEASE SEVERITY; ENZYME STRUCTURE; FLAVIVIRUS; GENE LOCUS; MOSQUITO; PHENOTYPE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN DOMAIN; SEROTYPE; VIRUS CARRIER; VIRUS MORPHOLOGY; VIRUS STRAIN; AMINO ACID SEQUENCE; ANIMAL; BIOLOGY; CHEMICAL STRUCTURE; CHEMISTRY; CLUSTER ANALYSIS; GENETIC VARIABILITY; GENETICS; HUMAN; IMMUNOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PHYLOGENY; PROTEIN TERTIARY STRUCTURE; SEQUENCE ANALYSIS; VIRULENCE; VIRUS GENOME;

ARBOVIRUS; ARTHROPODA; DENGUE VIRUS; HEXAPODA; IXODIDA; MOSQUITO-BORNE VIRUSES; WEST NILE VIRUS;

VIRULENCE FACTOR; VIRUS PROTEIN; VIRUS RNA;

AMINO ACID SEQUENCE; ANIMALS; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; CONSENSUS SEQUENCE; CONSERVED SEQUENCE; FLAVIVIRUS; GENETIC VARIATION; GENOME, VIRAL; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PHENOTYPE; PHYLOGENY; PROTEIN STRUCTURE, TERTIARY; RNA, VIRAL; SEQUENCE ANALYSIS; VIRAL PROTEINS; VIRULENCE; VIRULENCE FACTORS;

EID: 77949311688     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2009.11.070     Document Type: Article

References (73)

1. Zell R., Krumbholz A., Wutzler P. Impact of global warming on viral diseases: what is the evidence?. Curr. Opin. Biotechnol. 2008, 19:652-660.
2. Gaunt M.W., Gould E.A. Rapid subgroup identification of the flaviviruses using degenerate primer E-gene RT-PCR and site specific restriction enzyme analysis. J. Virol. Methods 2005, 128:113-127.
3. Thiel H.J., Collett M.S., Gould E.A., Heinz F.X., Houghton M., Meyers G., et al. Family Flaviviridae. Virus Taxonomy, Eighth Report of the International Committee on Taxonomy of Viruses 2005, 981-998.
4. Gaunt M.W., Sall A.A., de Lamballerie X., Falconar A.K., Dzhivanian T.I., Gould E.A. Phylogenetic relationships of flaviviruses correlate with their epidemiology, disease association and biogeography. J. Gen. Virol. 2001, 82:1867-1876.
5. Mackenzie J.S., Lindsay M.D., Coelen R.J., Broom A.K., Hall R.A., Smith D.W. Arboviruses causing human disease in the Australasian zoogeographic region. Arch. Virol. 1994, 136:447-467.
6. Nisbet D.J., Lee K.J., van den Hurk A.F., Johansen C.A., Kuno G., Chang G.J., et al. Identification of new flaviviruses in the Kokobera virus complex. J. Gen. Virol. 2005, 86:121-124.
7. Gromowski G.D., Barrett N.D., Barrett A.D. Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virus. J. Virol. 2008, 82:8828-8837.
8. Monath T.P., Kanesa-Thasan N., Guirakhoo F., Pugachev K., Almond J., Lang J., et al. Recombination and flavivirus vaccines: a commentary. Vaccine 2005, 23:2956-2958.
9. Ishikawa T., Widman D.G., Bourne N., Konishi E., Mason P.W. Construction and evaluation of a chimeric pseudoinfectious virus vaccine to prevent Japanese encephalitis. Vaccine 2008, 26:2772-2781.
10. Beasley D.W.C., Lewthwaite P., Solomon T. Current use and development of vaccines for Japanese encephalitis. Expert Opin. Biol. Ther. 2008, 8:95-106.
11. Widman D.G., Ishikawa T., Fayzulin R., Bourne N., Mason P.W. Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation system. Vaccine 2008, 26:2762-2771.
12. Tang F., Zhang J.S., Liu W., Zhao Q.M., Zhang F., Wu X.M., et al. Short report: failure of Japanese encephalitis vaccine and infection in inducing neutralizing antibodies against West Nile virus, People's Republic of China. Am. J. Trop. Med. Hyg. 2008, 78:999-1001.
13. Barrett A.D.T. Flavivirus DNA vaccine with a kick. Nat. Biotechnol. 2008, 26:525-526.
14. Wiggan O., Huang C.Y.H., Silengo S.J., Kinney R.M., Osorio J.E., Stinchcomb D.T. Optimization of a chimeric DEN-2/West Nile vaccine. Am. J. Trop. Med. Hyg. 2007, 77:135.
15. El Garch H., Minke J.M., Rehder J., Richard S., Toulemonde C.E., Dinic S., et al. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse. Vet. Immunol. Immunopathol. 2008, 123:230-239.
16. Rico-Hesse R., Harrison L.M., Nisalak A., Vaughn D.W., Kalayanarooj S., Green S., et al. Molecular evolution of dengue type 2 virus in Thailand. Am. J. Trop. Med. Hyg. 1998, 58:96-101.
17. Danecek, P. & Schein, C. H. (in press). Flavitrack analysis of the structure and function of West Nile non-structural proteins. Int. J. Bioinformatics Res. Appl.
18. Misra M., Schein C.H. Flavitrack: an annotated database of flavivirus sequences. Bioinformatics 2007, 23:2645-2647.
19. Stoermer M.J., Chappell K.J., Liebscher S., Jensen C.M., Gan C.H., Gupta P.K., et al. Potent cationic inhibitors of West Nile virus NS2B/NS3 protease with serum stability, cell permeability and antiviral activity. J. Med. Chem. 2008, 51:5714-5721.
20. Schein C.H., Zhou B., Braun W. Stereophysicochemical variability plots highlight conserved antigenic areas in Flaviviruses. Virol. J. 2005, 2:40.
21. Lai C.Y., Tsai W.Y., Lin S.R., Kao C.L., Hu H.P., King C.C., et al. Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II. J. Virol. 2008, 82:6631-6643.
22. Ledizet M., Kar K., Foellmer H.G., Bonafe N., Anthony K.G., Gould L.H., et al. Antibodies targeting linear determinants of the envelope protein protect mice against West Nile virus. J. Infect. Dis. 2007, 196:1741-1748.
23. Modis Y., Ogata S., Clements D., Harrison S.C. Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J. Virol. 2005, 79:1223-1231.
24. Oliphant T., Nybakken G.E., Austin S.K., Xu Q., Bramson J., Loeb M., et al. Induction of epitope-specific neutralizing antibodies against West Nile virus. J. Virol. 2007, 81:11828-11839.
25. Sukupolvi-Petty S., Austin S.K., Purtha W.E., Oliphant T., Nybakken G.E., Schlesinger J.J., et al. Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes. J. Virol. 2007, 81:12816-12826.
26. Rey F.A. Dengue virus envelope glycoprotein structure: new insight into its interactions during viral entry. Proc. Natl Acad. Sci. USA 2003, 100:6899-6901.
27. Mathura V.S., Schein C.H., Braun W. Identifying property based sequence motifs in protein families and superfamilies: application to DNase-1 related endonucleases. Bioinformatics 2003, 19:1381-1390.
28. Schein C.H., Zhou B., Oezguen N., Mathura V.S., Braun W. Molego-based definition of the architecture and specificity of metal-binding sites. Proteins: Struct. Funct. Bioinf. 2005, 58:200-210.
29. Kuno G. Host range specificity of flaviviruses: correlation with in vitro replication. J. Med. Entomol. 2007, 44:93-101.
30. Lawrie C.H., Uzcategui N.Y., Armesto M., Bell-Sakyi L., Gould E.A. Susceptibility of mosquito and tick cell lines to infection with various flaviviruses. Med. Vet. Entomol. 2004, 18:268-274.
31. van der Most R.G., Harrington L.E., Giuggio V., Mahar P.L., Ahmed R. Yellow fever virus 17D envelope and NS3 proteins are major targets of the antiviral T cell response in mice. Virology 2002, 296:117-124.
32. Li P., Zheng Q.S., Wang Q., Li Y., Wang E.X., Liu J.J., et al. Immune responses of recombinant adenoviruses expressing immunodominant epitopes against Japanese encephalitis virus. Vaccine 2008, 26:5802-5807.
33. Oliphant T., Nybakken G.E., Engle M., Xu Q., Nelson C.A., Sukupolvi-Petty S., et al. Antibody recognition and neutralization determinants on domains I and II of West Nile virus envelope protein. J. Virol. 2006, 80:12149-12159.
34. Matsui K., Gromowski G.D., Li L., Schuh A.J., Lee J.C., Barrett A.D. Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III. Virology 2008, 384:16-20.
35. Pryor M.J., Carr J.M., Hocking H., Davidson A.D., Li P., Wright P.J. Replication of dengue virus type 2 in human monocyte-derived macrophages: comparisons of isolates and recombinant viruses with substitutions at amino acid 390 in the envelope glycoprotein. Am. J. Trop. Med. Hyg. 2001, 65:427-434.
36. Zivny J., DeFronzo M., Jarry W., Jameson J., Cruz J., Ennis F.A., Rothman A.L. Partial agonist effect influences the CTL response to a heterologous dengue virus serotype. J. Immunol. 1999, 163:2754-2760.
37. Mongkolsapaya J., Dejnirattisai W., Xu X., Vasanawathana S., Tangthawornchaikul N., Chairunsri A., et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat. Med. 2003, 9:921-927.
38. Kristensen D.M., Ward R.M., Lisewski A.M., Erdin S., Chen B.Y., Fofanov V.Y., et al. Prediction of enzyme function based on 3D templates of evolutionarily important amino acids. BMC Bioinformatics 2008, 9:17.
39. Murthy H.M., Clum S., Padmanabhan R. Dengue virus NS3 serine protease. Crystal structure and insights into interaction of the active site with substrates by molecular modeling and structural analysis of mutational effects. J. Biol. Chem. 1999, 274:5573-5580.
40. Chu J.J., Ng M.L. Interaction of West Nile virus with alpha v beta 3 integrin mediates virus entry into cells. J. Biol. Chem. 2004, 279:54533-54541.
41. Jindadamrongwech S., Thepparit C., Smith D.R. Identification of GRP 78 (BiP) as a liver cell expressed receptor element for dengue virus serotype 2. Arch. Virol. 2004, 149:915-927.
42. Lee J.W., Chu J.J., Ng M.L. Quantifying the specific binding between West Nile virus envelope domain III protein and the cellular receptor alphaVbeta3 integrin. J. Biol. Chem. 2006, 281:1352-1360.
43. Zhang Y., Zhang W., Ogata S., Clements D., Strauss J.H., Baker T.S., et al. Conformational changes of the flavivirus E glycoprotein. Structure 2004, 12:1607-1618.
44. Maillard R.A., Jordan M., Beasley D.W.C., Barrett A.D.T., Lee J.C. Long range communication in the envelope protein domain III and its effect on the resistance of West Nile virus to antibody-mediated neutralization. J. Biol. Chem. 2008, 283:613-622.
45. Hemmingsen J.M., Gernert K.M., Richardson J.S., Richardson D.C. The tyrosine corner: a feature of most Greek key beta-barrel proteins. Protein Sci. 1994, 3:1927-1937.
46. Barker W.C., Mazumder R., Vasudevan S., Sagripanti J.L., Wu C.H. Sequence signatures in envelope protein may determine whether flaviviruses produce hemorrhagic or encephalitic syndromes. Virus Genes 2009, 39:1-9.
47. Roehrig J.T. Antigenic structure of flavivirus proteins. Adv. Virus Res. 2003, 59:141-175.
48. Leitmeyer K.C., Vaughn D.W., Watts D.M., Salas R., Villalobos I., de Chacon, et al. Dengue virus structural differences that correlate with pathogenesis. J. Virol. 1999, 73:4738-4747.
49. Rico-Hesse R. Dengue virus evolution and virulence models. Clin. Infect. Dis. 2007, 44:1462-1466.
50. Gubler D.J. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol. 2002, 10:100-103.
51. Guzman M.G., Kouri G. Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J. Clin. Virol. 2003, 27:1-13.
52. Loke H., Bethell D.B., Phuong C.X.T., Dung M., Schneider J., White N.J., et al. Strong HLA class I-restricted T cell responses in dengue hemorrhagic fever: a double-edged sword?. J. Infect. Dis. 2001, 184:1369-1373.
53. Schein C.H., Ozgun N., Izumi T., Braun W. Total sequence decomposition distinguishes functional modules, "molegos" in apurinic/apyrimidinic endonucleases. BMC Bioinformatics 2002, 3:37.
54. Higgs S. Influences of arthropod vectors on encephalitic arboviruses. Neurotropic Viral Infections 2008, 362-381. Cambridge University Press, New York, NY. C. Reiss (Ed.).
55. Hahn C.S., Hahn Y.S., Rice C.M., Lee E., Dalgarno L., Strauss E.G., Strauss J.H. Conserved elements in the 3′ untranslated region of flavivirus RNAs and potential cyclization sequences. J. Mol. Biol. 1987, 198:33-41.
56. Mandl C.W., Holzmann H., Kunz C., Heinz F.X. Complete genomic sequence of Powassan virus: evaluation of genetic elements in tick-borne versus mosquito-borne flaviviruses. Virology 1993, 194:173-184.
57. Khromykh A.A., Meka H., Guyatt K.J., Westaway E.G. Essential role of cyclization sequences in flavivirus RNA replication. J. Virol. 2001, 75:6719-6728.
58. Markoff L. 5′- and 3′-noncoding regions in flavivirus RNA. Adv. Virus Res. 2003, 59:177-228.
59. Thurner C., Witwer C., Hofacker I.L., Stadler P.F. Conserved RNA secondary structures in Flaviviridae genomes. J. Gen. Virol. 2004, 85:1113-1124.
60. Kofler R.M., Hoenninger V.M., Thurner C., Mandl C.W. Functional analysis of the tick-borne encephalitis virus cyclization elements indicates major differences between mosquito-borne and tick-borne flaviviruses. J. Virol. 2006, 80:4099-4113.
61. Hung J.J., Hsieh M.T., Young M.J., Kao C.L., King C.C., Chang W. An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells. J. Virol. 2004, 78:378-388.
62. Kanai R., Kar K., Anthony K., Gould L.H., Ledizet M., Fikrig E., et al. Crystal structure of West Nile virus envelope glycoprotein reveals viral surface epitopes. J. Virol. 2006, 80:11000-11008.
63. Rey F.A., Heinz F.X., Mandl C., Kunz C., Harrison S.C. The envelope glycoprotein from tick-borne encephalitis virus at 2Å resolution. Nature 1995, 375:291-298.
64. Lieberman M.M., Nerurkar V.R., Luo H.Y., Cropp B., Carrion R., de la Garza M., et al. Immunogenicity and protective efficacy of a recombinant subunit West Nile virus vaccine in rhesus monkeys. Clin. Vaccine Immunol. 2009, 16:1332-1337.
65. Chu J.H.J., Chiang C.C.S., Ng M.L. Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection. J. Immunol. 2007, 178:2699-2705.
66. Chin J.F.L., Chu J.J.H., Ng M.L. The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry. Microbes Infect. 2007, 9:1-6.
67. Babu J.P., Pattnaik P., Gupta N., Shrivastava A., Khan M., Rao P.V.L. Immunogenicity of a recombinant envelope domain III protein of dengue virus type-4 with various adjuvants in mice. Vaccine 2008, 26:4655-4663.
68. Nybakken G.E., Oliphant T., Johnson S., Burke S., Diamond M.S., Fremont D.H. Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature 2005, 437:764-768.
69. Oezguen N., Zhou B., Negi S.S., Ivanciuc O., Schein C.H., Labesse G., Braun W. Comprehensive 3D-modeling of allergenic proteins and amino acid composition of potential conformational IgE epitopes. Mol. Immunol. 2008, 45:3740-3747.
70. Schein C.H., Nagle G.T., Page J.S., Sweedler J.V., Xu Y., Painter S.D., Braun W. Aplysia attractin: biophysical characterization and modeling of a water-borne pheromone. Biophys. J. 2001, 81:463-472.
71. Soman K.V., Midoro-Horiuti T., Ferreon J.C., Goldblum R.M., Brooks E.G., Kurosky A., et al. Homology modeling and characterization of IgE epitopes of mountain cedar allergen Jun a 3. Biophys. J. 2000, 79:1601-1609.
72. DeLano W.L. The PyMOL Molecular Graphics System 2002, DeLano Scientific, Palo Alto, CA.
73. Venkatarajan M.S., Braun W. New quantitative descriptors of amino acids based on multidimensional scaling of a large number of physical-chemical properties. J. Mol. Model. 2001, 7:445-453.